The findings by Kim et al. [134] demonstrate that MALAT1 is a metastasis-suppressing lncRNA rather than a metastasis promoter in breast cancer, raising caution about targeting MALAT1 as an antimetastatic strategy. The gene discussed is MALAT1; the disease is breast carcinoma.